Medicharme has raised debt from BlackRock
Medicharme has raised US$90 million debt from BlackRock to support its ambitious growth plan that involves the acquisition of 500 beds per year, including operating and real estate entities.
Medicharme operates a chain of nursing homes, residential units for disabled elderly people and accommodations for autonomous elderly people. Medicharme focuses on the high-end of the dependency spectrum, including dedicated alzheimer units.
Oaklins' team in France assisted Medicharme in this transaction.
Talk to the deal team
Related deals
ERBC (ex CERB) has acquired RTC
The European Research Biology Center (ERBC) has acquired the Research Toxicology Center (RTC).
Learn moreEnterprises ImportFab Inc. has been acquired by Labomar S.p.A
Labomar S.p.A., a leading company in the research, development and production of food supplements, medical devices and foods for specific medical and cosmetic purposes, has acquired Enterprises ImportFab Inc., a Canadian firm based in Montréal that operates in the North American pharmaceutical, cosmetic and nutraceutical market. The operation has been carried out in partnership with SIMEST that will participate in the acquisition and will hold a minority share of the Canadian company.
Learn moreGroupe Serenis has raised capital from BNP Paribas Dev., GSO Capital and Multicroissance
Groupe Serenis has raised US$8 million in equity from BNP Paribas Developpement, Credit Agricole GSO Capital and Multicroissance Banque Populaire Occitane.
Learn more